These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2737478)

  • 21. The relationship between foveal outer nuclear layer thickness in the active and resolved phases of central serous chorioretinopathy treated with half-dose photodynamic therapy.
    Yu J; Lei Y; Chang Q; Xu G; Ye X; Li L; Jiang C
    BMC Ophthalmol; 2019 Mar; 19(1):84. PubMed ID: 30922273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differential diagnostic OCT-criteria of acute and chronic central serous chorioretinopathy].
    Doga AV; Klepinina OB; Pedanova EK; Mushkova IA
    Vestn Oftalmol; 2017; 133(6):10-15. PubMed ID: 29319664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy.
    Framme C; Walter A; Gabler B; Roider J; Sachs HG; Gabel VP
    Acta Ophthalmol Scand; 2005 Apr; 83(2):161-7. PubMed ID: 15799726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhegmatogenous retinal detachments caused by paravascular vitreoretinal traction.
    Benson WE; Tasman W
    Arch Ophthalmol; 1984 May; 102(5):669-70. PubMed ID: 6721748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
    Pryds A; Larsen M
    Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified Photodynamic Therapy Treatment of Central Serous Chorioretinopathy.
    Putnam CM; Vang SS
    Optom Vis Sci; 2016 Jul; 93(7):760-71. PubMed ID: 27058592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Central serous chorioretinopathy and systemic steroid therapy].
    Chaine G; Haouat M; Menard-Molcard C; Favard C; Vignal-Clermont C; Campinchi-Tardy F; Massin P; Gaudric A; Badelon I; Nicolon L; Sabatier P; Guillevin L
    J Fr Ophtalmol; 2001 Feb; 24(2):139-46. PubMed ID: 11240484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.
    Shin WB; Kim MK; Lee CS; Lee SC; Kim H
    Korean J Ophthalmol; 2015 Dec; 29(6):389-95. PubMed ID: 26635455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new approach for studying the retinal and choroidal circulation].
    Yoneya S
    Nippon Ganka Gakkai Zasshi; 2004 Dec; 108(12):836-61; discussion 862. PubMed ID: 15656089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental serous retinal detachment and focal pigment epithelial damage.
    Negi A; Marmor MF
    Arch Ophthalmol; 1984 Mar; 102(3):445-9. PubMed ID: 6703994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal Pigment Epithelial Features in Central Serous Chorioretinopathy Identified by Polarization-Sensitive Optical Coherence Tomography.
    Roberts P; Baumann B; Lammer J; Gerendas B; Kroisamer J; Bühl W; Pircher M; Hitzenberger CK; Schmidt-Erfurth U; Sacu S
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1595-603. PubMed ID: 27046123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of serous detachments of the retinal pigment epithelium.
    Meredith TA; Braley RE; Aaberg TM
    Am J Ophthalmol; 1979 Oct; 88(4):643-51. PubMed ID: 92197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous closure of retinal pigment epithelium microrip in the natural course of central serous chorioretinopathy.
    Gupta V; Gupta P; Dogra MR; Gupta A
    Eye (Lond); 2010 Apr; 24(4):595-9. PubMed ID: 19648895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of primary rhegmatogenous retinal detachment not involving the fovea.
    Ho SF; Fitt A; Frimpong-Ansah K; Benson MT
    Eye (Lond); 2006 Sep; 20(9):1049-53. PubMed ID: 16151481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy.
    Shukla D; Kolluru C; Vignesh TP; Karthikprakash S; Kim R
    Eye (Lond); 2008 Jan; 22(1):100-6. PubMed ID: 16732205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subretinal exudative deposits in central serous chorioretinopathy.
    Ie D; Yannuzzi LA; Spaide RF; Rabb MF; Blair NP; Daily MJ
    Br J Ophthalmol; 1993 Jun; 77(6):349-53. PubMed ID: 8318481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic multiple serous detachments of the retinal pigment epithelium followed by bilateral central serous chorioretinopathy: a case report.
    Bandello F; Incorvaia C; Parmeggiani F; Sebastiani A
    Ophthalmologica; 2000; 214(5):362-7. PubMed ID: 10965253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topography-guided identification of leakage point in central serous chorioretinopathy: a base for fluorescein angiography-free focal laser photocoagulation.
    Maltsev DS; Kulikov AN; Chhablani J
    Br J Ophthalmol; 2018 Sep; 102(9):1218-1225. PubMed ID: 29301768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital indocyanine green videoangiography of central serous chorioretinopathy.
    Guyer DR; Yannuzzi LA; Slakter JS; Sorenson JA; Ho A; Orlock D
    Arch Ophthalmol; 1994 Aug; 112(8):1057-62. PubMed ID: 8053819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous involution of subfoveal neovascularization.
    Campochiaro PA; Morgan KM; Conway BP; Stathos J
    Am J Ophthalmol; 1990 Jun; 109(6):668-75. PubMed ID: 2346196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.